Nutaria, a pioneering nutraceutical R&D company, has revolutionized drug delivery with its targeted delivery system. Traditional "neuro-protective" options for brain health, such as nootropic supplements, often fail due to low absorption and bioavailability, meaning vital active ingredients do not reach their intended sites effectively.

 

In response, Nutaria developed a novel approach that utilizes food molecules as natural "taxis" to deliver active ingredients directly to specific tissues or organs. This system ensures dramatically improved internalization and effectiveness of therapeutic agents, such as antioxidants and anti-inflammatories, directly to target areas.

 

Patented and composed entirely of FDA and EFSA-approved food ingredients, Nutaria's technology is designed to improve the lives of people with neurodegenerative conditions by focusing on early treatment and prevention, thereby limiting the impact of these medical conditions on their health.

​

Currently, Nutaria is in the advanced preclinical stages of developing a drug specifically for early Parkinson's disease, underscoring our commitment to pioneering treatments that offer hope and improved quality of life for patients.